hesperidin has been researched along with Osteoporosis in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 4 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bellini, MZ; Buchaim, DV; Buchaim, RL; de Marchi, MÂ; Detregiachi, CRP; Fideles, SOM; Flato, UAP; Gardizani, TP; Ortiz, AC; Pagani, BT; Pereira, ESBM; Pilon, JPG; Ponce, JB; Reis, CHB; Trazzi, BFM; Veronez, FS | 1 |
Duan, TH; Feng, W; Hu, HY; Jiang, XY; Wang, XG; Zhang, ZZ | 1 |
Chen, H; Liu, L; Ni, L; Yang, Y; Yu, D; Zheng, J | 1 |
Chang, YW; Gu, W; Li, ZQ; Sun, J; Wei, XE; Zhu, WJ | 1 |
Cai, C; Dong, Y; Gao, Y; Guo, F; Huang, H; Liu, C; Liu, H; Qi, D; Xiao, J; Zhao, L; Zhu, M | 1 |
Cheng, J; Hong, G; Kenny, J; Lin, X; Liu, Q; Qin, A; Quinn, JMW; Tan, Z; Tickner, J; Wang, T; Xu, J; Yuan, J; Zhao, J; Zhou, L | 1 |
Abd El-Haleem, MR; Amer, MG; Karam, RA; Shehata, AS | 1 |
Barron, D; Chee, W; Coxam, V; Davicco, MJ; Gil-Izquierdo, A; Habauzit, V; Horcajada, MN; Lebecque, P; Morand, C; Nielsen, IL; Offord, E; Trzeciakiewicz, A; Williamson, G | 1 |
Chan, FL; Chen, S; Cheung, WH; Chow, S; Leung, LK; Li, F | 1 |
Chiba, H; Ishimi, Y; Kanazawa, K; Masuyama, R; Suzuki, K; Uehara, M; Wang, X; Wu, J | 1 |
Uehara, M | 1 |
Chee, WS; Coxam, V; Davicco, MJ; Gil-Izquierdo, A; Habauzit, V; Horcajada, MN; Lebecque, P; Mardon, J; Morand, C; Offord, E; Trzeciakiewicz, A | 1 |
2 review(s) available for hesperidin and Osteoporosis
Article | Year |
---|---|
Therapeutic Effects of Citrus Flavonoids Neohesperidin, Hesperidin and Its Aglycone, Hesperetin on Bone Health.
Topics: Bone Density; Citrus; Flavanones; Flavonoids; Hesperidin; Osteoporosis | 2022 |
[Prevention of osteoporosis by foods and dietary supplements. Hesperidin and bone metabolism].
Topics: Animals; Bone and Bones; Flavonoids; Hesperidin; Mice; Osteoporosis; Rats | 2006 |
10 other study(ies) available for hesperidin and Osteoporosis
Article | Year |
---|---|
Hesperidin Anti-Osteoporosis by Regulating Estrogen Signaling Pathways.
Topics: Aged; Animals; Cell Differentiation; Estrogens; Hesperidin; Humans; Molecular Docking Simulation; Osteoblasts; Osteogenesis; Osteoporosis; Quality of Life; Signal Transduction; Zebrafish | 2023 |
Hesperetin alleviated glucocorticoid-induced inhibition of osteogenic differentiation of BMSCs through regulating the ERK signaling pathway.
Topics: Butadienes; Cell Differentiation; Dexamethasone; Extracellular Signal-Regulated MAP Kinases; Glucocorticoids; Hesperidin; Humans; MAP Kinase Signaling System; Mesenchymal Stem Cells; Nitriles; Osteogenesis; Osteoporosis; Primary Cell Culture | 2021 |
Neohesperidin promotes the osteogenic differentiation of bone mesenchymal stem cells by activating the Wnt/β-catenin signaling pathway.
Topics: Alkaline Phosphatase; beta Catenin; Bone and Bones; Calcium; Cell Differentiation; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Hesperidin; Humans; Mesenchymal Stem Cells; Osteogenesis; Osteoporosis; Signal Transduction; Wnt Signaling Pathway | 2021 |
Hesperetin suppresses RANKL-induced osteoclastogenesis and ameliorates lipopolysaccharide-induced bone loss.
Topics: Animals; Cell Proliferation; Gene Expression Regulation; Genes, fos; Hesperidin; Humans; Lipopolysaccharides; Mice; Mitogen-Activated Protein Kinases; Molecular Structure; NF-kappa B; NFATC Transcription Factors; Osteogenesis; Osteoporosis; RANK Ligand; RAW 264.7 Cells | 2019 |
Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
Topics: Animals; Apoptosis; Blotting, Western; Bone Marrow Cells; Bone Resorption; Calcium; Cathepsin K; Cell Differentiation; Cells, Cultured; Female; Genes, Reporter; Hesperidin; Luciferases; Macrophages; Mice, Inbred C57BL; NF-kappa B; NF-KappaB Inhibitor alpha; NFATC Transcription Factors; Osteoclasts; Osteoporosis; Ovariectomy; Proteolysis; RANK Ligand; Real-Time Polymerase Chain Reaction; RNA, Messenger; Tartrate-Resistant Acid Phosphatase | 2017 |
The ability of hesperidin compared to that of insulin for preventing osteoporosis induced by type I diabetes in young male albino rats: A histological and biochemical study.
Topics: Animals; Bone and Bones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hesperidin; Hypoglycemic Agents; Insulin; Male; Osteoporosis; Random Allocation; Rats; Real-Time Polymerase Chain Reaction | 2017 |
Increased bioavailability of hesperetin-7-glucoside compared with hesperidin results in more efficient prevention of bone loss in adult ovariectomised rats.
Topics: Animals; Biological Availability; Bone Density; Bone Remodeling; Dietary Supplements; Drug Evaluation, Preclinical; Female; Femur; Hesperidin; Organ Size; Osteoporosis; Ovariectomy; Rats; Rats, Wistar; Uterus; Weight Gain | 2009 |
The citrus flavonone hesperetin prevents letrozole-induced bone loss in a mouse model of breast cancer.
Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Citrus; Estradiol; Female; Hesperidin; Humans; Letrozole; MCF-7 Cells; Mice; Mice, Nude; Nitriles; Osteoporosis; Selective Estrogen Receptor Modulators; Triazoles; Xenograft Model Antitumor Assays | 2013 |
Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice.
Topics: Animals; Body Weight; Bone and Bones; Bone Density; Citrus; Female; Flavonoids; Hesperidin; Lipids; Liver; Mice; Organ Size; Osteoporosis; Ovariectomy; Tomography, X-Ray Computed | 2003 |
Hesperidin inhibits ovariectomized-induced osteopenia and shows differential effects on bone mass and strength in young and adult intact rats.
Topics: Age Factors; Amino Acids; Animals; Biomechanical Phenomena; Body Composition; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Cholesterol; Disease Models, Animal; Female; Femur; Hesperidin; Hypolipidemic Agents; Osteocalcin; Osteoporosis; Ovariectomy; Rats; Rats, Wistar; Triglycerides; Uterus | 2008 |